Traduction de «for stroke trial » (Français → Néerlandais) :

L’étude HERS (chez des femmes présentant une affection coronarienne) et l’étude WEST (Women’s Estrogen for Stroke Trial chez des femmes avec des antécédents récents d’accident cérébrovasculaire ischémique ou d’A.I. T., traitées par 1 mg p.j. de 17β-estradiol, et suivies pendant 2,8 ans en moyenne) ne montrent aucun effet de la substitution hormonale sur l’incidence d’accident cérébro-vasculaire.
De HERS-studie (bij vrouwen met coronairlijden) en de WEST-studie (Women’s Estrogen for Stroke Trial bij vrouwen met antecedenten van recent ischemisch cerebrovasculair accident of T.I. A., met gebruik van 1 mg per dag 17ß-estradiol en een gemiddelde followupduur van 2,8 jaar) tonen geen effect van HST op de incidentie van cerebrovasculair accident.

The graphs „Medical treatment‰ and „trial centres‰ show the results of the ACST/ACAS trials (expressed as constant hazards of stroke or death from the trials and age dependent hazards of all other cause mortality from the Flemish male life table at age 70 in the year 2000). 18 Intervention starts with a short period of high (peri-procedural) mortality, but the lower post-procedural hazard of death will overtake the higher hazard of medical treatment.
The graphs „Medical treatment‰ and „trial centres‰ show the results of the ACST/ACAS trials (expressed as constant hazards of stroke or death from the trials and age dependent hazards of all other cause mortality from the Flemish male life table at age 70 in the year 2000).[18] Intervention starts with a short period of high (peri-procedural) mortality, but the lower post-procedural hazard of death will overtake the higher hazard of medical treatment.

randomized trials.1 Effective strategies for the secondary prevention of stroke include treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1). 1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1). 2, 3
treatment of hypertension and hyperlipidemia, antithrombotic therapy for patients with atrial fibrillation, and antiplatelet therapy (Evidence level 1).1 Statins are effective in the prevention of stroke, although evidence remains limited to heart disease patients (Evidence level 1).2, 3

Ces recommandations parues dans les Folia d’août 2000 reposent entre autres sur l’étude SPIRIT («Stroke Prevention in Reversible Ischemia Trial»), une étude randomisée contrôlée, dans laquelle un anticoagulant oral (avec un INR recherché entre 3,0 et 4,5) et l’acide acétylsalicylique (30 mg p.j. ou plus) ont été comparés en prévention secondaire d’un AVC chez 1.316 patients sans cardiopathie emboligène.
De aanbevelingen in de Folia van augustus 2000 berustten vooral op de SPIRITstudie (“Stroke Prevention in Reversible Ischemia Trials”), een gerandomiseerde, gecontroleerde studie, waarbij in de secundaire preventie van cerebrovasculair accident een oraal anticoagulans (streefwaarde voor de INR tussen 3,0 en 4,5) en acetylsalicylzuur (30 mg p.d. of meer) werden vergeleken bij 1.316 patiënten zonder emboligene cardiopathie.

19. Halliday A, Mansfield A, Marro J, Peto C, Peto R, Potter J, et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.
disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial.

Ces recommandations parues dans les Folia d’ août 2000 reposent entre autres sur l’étude SPIRIT (" Stroke Prevention in Reversible Ischemia Trial "), une étude randomisée contrôlée, dans laquelle un anticoagulant oral (avec un INR recherché entre 3,0 et 4,5) et l’acide acétylsalicylique (30 mg p.j. ou plus) ont été comparés en prévention secondaire d’un AVC chez 1.316 patients sans cardiopathie emboligène.
De aanbevelingen in de Folia van augustus 2000 berustten vooral op de SPIRIT-studie (" Stroke Prevention in Reversible Ischemia Trials "), een gerandomiseerde, gecontroleerde studie, waarbij in de secundaire preventie van cerebrovasculair accident een oraal anticoagulans (streefwaarde voor de INR tussen 3,0 en 4,5) en acetylsalicylzuur (30 mg p.d. of meer) werden vergeleken bij 1.316 patiënten zonder emboligene cardiopathie.

LM etal. Aspirin and clopidogrel compared with clopidogrel alone afterrecent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.
LM et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-riskpatients (MATCH): randomized, double-blind, placebo-controlled trial.

The medical risk of any stroke or death in the forthcoming five years in symptomatic persons of the NASCET/ECST trials with a stenosis of 50% (according to the NASCET method) was 21%. 14 That risk was further increased by male sex (23%), old age ( 75 y, 31%), time since last event (< 2 weeks, 32%) and diabetes.
The medical risk of any stroke or death in the forthcoming five years in symptomatic persons of the NASCET/ECST trials with a stenosis of 50% (according to the NASCET method) was 21%.[14] That risk was further increased by male sex (23%), old age ( 75 y, 31%), time since last event (< 2 weeks, 32%) and diabetes.